HBV Discovery Services
A Platform Supporting HBV Drug Discovery
A broad assay platform for the discovery of agents for the treatment of chronic HBV infection.
Services for assay establishment and validation, compound screening and profiling, and support of preclinical studies and clinical trials.
- Drug screening using HBV producing cell lines
- HBV infectious assays
- Reporter assays
- Core protein expression
- Compound profiling
- Clinical virology
- Animal models
- Immunological assays supporting animal models
HBV Drug Discovery
Related Content
STAT proteins are key mediators of cellular immunity, proliferation, apoptosis, and differentiation. STATs are known to play a role in...
VIEW RESOURCEAt the Covalent Drug Discovery 2023 Summit and Fragments 2024 Conference, we presented a case study on Bruton’s tyrosine kinase (BTK)...
VIEW RESOURCE